Chinese Innovative Drug Developer Hutchison MediPharma Could See Spin-off Ahead, Says Founder
This article was originally published in PharmAsia News
Executive Summary
BEIJING - The head of Hutchison MediPharma, one of China's most promising developers of innovative drugs, has disclosed that with a series of milestones met over the past months with pipeline medicines, the outfit is mulling whether to become independent via a spin-off